TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Department of Agriculture (USDA) has granted conditional approval for a ...

A New Jersey pharmaceutical company has received a “a conditional license" for its bird flu vaccine for use in chickens. An ...

The U.S. Department of Agriculture has given a conditional approval to Zoetis to use its bird flu vaccine in poultry, the ...

Zoetis was granted a conditional license for its avian influenza vaccine for use in chickens. It's a step closer to fighting the bird flu outbreaks that continue to devastate flocks.

Over the last 30 days, 151 flocks have been confirmed to have avian flu, affecting more than 23 million birds, according to ...

Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the ...

Zoetis slightly topped analyst estimates for profitability and met those for revenue in its fourth quarter. But as investors ...

In the past three years, the U.S. Department of Agriculture (USDA) says about 150 million birds died across the country due ...

Zoetis has been granted a conditional license from the USDA for its avian flu vaccine. Since February 2022, more than 150 ...

BTIG lowered the firm’s price target on Zoetis (ZTS) to $200 from $225 and keeps a Buy rating on the shares. The company delivered an in-line ...

Q4 2024 Earnings Call Transcript February 13, 2025 Zoetis Inc. beats earnings expectations. Reported EPS is $1.4, ...

Zoetis on Feb. 14 received a conditional license from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus.